Tags: vaccine

A new study from University of Georgia researchers describes a vaccine that could be the first clinically approved immunization to protect against invasive fungal infections, a growing concern as antifungal drug resistance increases:   The experimental vaccine is designed to protect against the three most common fungal pathogens that are responsible for more than 80% of fatal fungal infections. The study tested the vaccine’s efficacy…

Parasitologist Samarchith “Sam” Kurup has been awarded a five-year National Institutes of Health grant to study the natural immune response to the Plasmodium parasite in liver cells, with designs on uncovering how the human immune system naturally fights malaria in the liver stage will lead to an effective malaria vaccine. Our colleagues in the Office of research share the story: Malaria is one of the most studied parasitic…

On Oct. 15, the university drew the final 25 names in its vaccine drawing, selecting the last of the cash prize winners. The $100,000 incentive program was supported by the Higher Education Emergency Relief Fund III. The first 50 names were selected Sept. 15 and another 25 names were selected Sept. 30. More than 24,000 entries were submitted for the drawing, which was conducted by UGA’s Office of Institutional Research with results verified by…

Four University of Georgia experts answered some of the most frequently asked questions about COVID-19 vaccines in a recent virtual panel discussion held on campus. Moderated by Dr. Shelley Nuss, dean of the Augusta University/University of Georgia Medical Partnership, the panelists discussed a variety of topics related to vaccine safety and efficacy. And they shared their thoughts on why it is so important for everyone who is eligible and…

The UGA Athletic Association is making a strong statement about vaccinations, working with the Georgia Department of Public Health to promote the increased availability of the COVID-19 vaccines in the state and encourage those that wish to receive it to make an appointment. This past Saturday, dozens of UGA Athletic Association coaches and staff members received their first dose: Among those that have now received at least one dose of the…

What do the 3,000-year-old actions of an Egyptian pharaoh say about how we should tackle the biggest challenges of the 21st century? Quite a bit, according to anthropologists at the University of Georgia who analyzed archeological evidence over thousands of years to examine how societies have approached adversity. Their work suggests that rigid, top-down approaches to complex problems have been a doomed strategy throughout human history.…

University of Georgia staff member Doug Lloyd, a systems administrator in the Franklin College of Arts and Sciences Office of Information Technology, is participating in the two-year Phase 3 trial of the investigational COVID-19 vaccine known as mRNA-1273. An interim analysis of the trial data suggests that the vaccine is safe and effective at preventing symptomatic COVID-19 in adults. For Lloyd, the experience provides an…